Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2013 Nov;4(11):1318-20.

Prevention of renal damage by treating hyperuricemia

Affiliations
Case Reports

Prevention of renal damage by treating hyperuricemia

Azar Nickavar. Int J Prev Med. 2013 Nov.

Abstract

Nephrolithiasis, obstructive renal failure, essential hypertension, and chronic tubulointerstitial nephritis have been considered as the renal complications of hyperuricemia. Massive proteinuria has been rarely reported as the primary manifestation of increased serum uric acid. This is the report of a child presented with proteinuira, hypertension, and glomerular scelrosis secondary to hypouricosuric hyperuricemia, who was treated by uric acid lowering management.

Keywords: Glomerular sclerosis; hypertension; hyperuricemia; proteinuria.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None declared.

Figures

Figure 1
Figure 1
Diffuse global glomeruli sclerosis (×400, PAS stain)
Figure 2
Figure 2
Segmental sclerosis in one glomerule (×400, PAS stain)

Similar articles

Cited by

References

    1. Preitner F, Bonny O, Laverrière A, Rotman S, Firsov D, Da Costa A, et al. Glut9 is a major regulator of urate homeostasis and its genetic inactivation induces hyperuricosuria and urate nephropathy. Proc Natl Acad Sci. 2009;106:15501–6. - PMC - PubMed
    1. Bellinghieri G, Santoro D, Savica V. Pharmacological treatment of acute and chronic hyperuricemia in kidney diseased patients. Contrib Nephrol. 2005;147:149–60. - PubMed
    1. Van’t Hoff WG. Renal menifestations of metabolic disorders. In: Avner ED, Harmon WE, Niaudet P, Yoshokawa N, editors. Pediatric nephrology. 6th ed. Heidelberg, Germany: Springer-Verlag; 2009. pp. 1219–34.
    1. Nakagawa T, Mazzali M, Kang DH, Sánchez-Lozada LG, Herrera-Acosta J, Johnson RJ. Uric acid: A uremic toxin? Blood Purif. 2006;24:67–70. - PubMed
    1. Williams T, Kimo C, Stine KC, Patrick D, Walker PD, Ilyas M, Wang Y, Richard T, Blaszak RT. A patient with hyperuricemia and renal failure: Answer. Pediatr Nephrol. 2007;22:950–3. - PubMed

Publication types

LinkOut - more resources